Загрузка...
Development of dual-drug-loaded stealth nanocarriers for targeted and synergistic anti-lung cancer efficacy
Combination chemotherapy is widely exploited for suppressing drug resistance and achieving synergistic anticancer efficacy in the clinic. In this paper, the nanostructured targeting methotrexate (MTX) plus pemetrexed (PMX) chitosan nanoparticles (CNPs) were developed by modifying methoxy polye (thyl...
Сохранить в:
| Опубликовано в: : | Drug Deliv |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Taylor & Francis
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6263111/ https://ncbi.nlm.nih.gov/pubmed/30472899 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10717544.2018.1477856 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|